Picture of Neuronetics logo

STIM Neuronetics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Neuronetics Inc reports results for the quarter ended September 30 - Earnings Summary

* Neuronetics Inc  STIM.OQ  reported a quarterly adjusted
loss
of 44 cents​​ per share for the quarter ended September 30,
lower than the same quarter last year, when the company reported
EPS of -33 cents.  The mean expectation of four analysts for the
quarter was for a loss of 23 cents per share. Wall Street
expected results to range from -26 cents to -20 cents per share.
    * Revenue rose 3.6% to $18.53 million from a year ago;
analysts
expected $19.13 million. 
    * Neuronetics Inc's reported EPS for the quarter was a loss
of 44
cents​.
    * The company reported a quarterly loss of $13.34 million.
    * Neuronetics Inc shares had risen by 44.8% this quarter and
lost 62.1% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 1.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for Neuronetics Inc
is 3.00 
This summary was machine generated from LSEG data November 12 at
03:29 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.23          -0.44          Missed
 Jan. 1 0001       -0.27          -0.33          Missed
 Mar. 31 2024      -0.31          -0.27          Beat
 Dec. 31 2023      -0.26          -0.19          Beat

Recent news on Neuronetics

See all news